Smith + Nephew (NYSE:SNN) announced today that it launched the Novostitch Pro meniscal repair system after winning CE Mark approval.
London-based Smith + Nephew is launching the Novostitch Pro in Europe to expand meniscal repair options where the only previous option was removal, according to a news release. The system repairs meniscal tears and closes the gap on meniscectomy.
Novostitch Pro allows surgeons to place stitches arthroscopically in tight joint compartments, using a meniscus-to-meniscus circumferential compression stitch to repair tears that may not have been repaired in the past, the company said.
Smith + Nephew has now made the Novostitch Pro meniscal repair system commercially available in the U.S., Europe, the Middle East, Africa and other select countries.
“We are delighted to be able to offer this ground-breaking technology to surgeons in Europe,” Smith + Nephew VP of marketing for sports medicine EMEA Terry Byca said in the release. “The Novostitch Pro Meniscal Repair System’s unique capabilities, along with our industry-leading all Tears, all repairs meniscal repair portfolio brings us closer to making repair, not removal, the standard-of-care for meniscal tears.”
